Study for early SPG4 symptoms in family members
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study looks at people in families with a known SPG4 gene change (a SPAST mutation) to understand early, subtle signs and the beginning of symptoms. It may help researchers find better ways to detect SPG4 earlier, before full walking problems start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old
- You are a parent, child, or sibling of someone with SPG4 or a known SPAST mutation
- The family member’s SPAST gene mutation is known in your family
- You should not already have clear, established walking stiffness (severe spastic gait)
- You should not be enrolled in any other interventional (treatment-changing) study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the causes and biology (“biomarkers”) of hereditary spastic paraplegias and related conditions. You may join as someone with the condition, a family member without symptoms, or a healthy person, to help researchers understand what’s happening in the nervous system.
This study tracks how ataxias and related movement disorders progress over time. By joining, you help researchers learn more about these conditions and prepare for future treatments.
This study follows people with hereditary spastic paraplegia that started in childhood to better understand how the condition progresses over time. It may help doctors learn what to expect and how to plan care, using genetic information and family history.
This trial aims to build a research network and gather information from people with two genetic types of hereditary spastic paraplegia (SPG4 and SPG5A). It will help doctors better understand these conditions and improve care.
This trial tests a one-time gene therapy (BFB-101) for children with a rare genetic condition called SPG47, which causes problems with movement and development. The therapy aims to replace the faulty gene to help improve symptoms.
This study looks at genes (DNA) to understand an inherited condition that causes gradually worsening leg stiffness. It may help researchers learn what causes the condition and potentially guide future care.
Hear when a new Hereditary Spastic Paraplegia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.